Analyst Price Target is $31.00
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Healthcare Trust of America in the last 3 months. The average price target is $31.00, with a high forecast of $34.00 and a low forecast of $28.00. The average price target represents a ∞ upside from the last price of $0.00.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Healthcare Trust of America. This rating has held steady since September 2022, when it changed from a Hold consensus rating.
Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.